Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia

Chimeric antigen receptor (CAR) T-cell technology has seen a rapid development over the last decade mostly due to the potential that these cells may have in treating malignant diseases. It is a generally accepted principle that very few therapeutic compounds deliver a clinical response without treat...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Ciprian Tomuleasa, Shigeo Fuji, Cristian Berce, Anca Onaciu, Sergiu Chira, Bobe Petrushev, Wilhelm-Thomas Micu, Vlad Moisoiu, Ciprian Osan, Catalin Constantinescu, Sergiu Pasca, Ancuta Jurj, Laura Pop, Ioana Berindan-Neagoe, Delia Dima, Shigehisa Kitano
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Frontiers Media S.A. 2018-02-01
سلاسل:	Frontiers in Immunology
الموضوعات:	acute lymphoblastic leukemia immunotherapy chimeric antigen receptor T-cell therapy (CAR-T) gene transferred T-cell therapy adoptive cell transfer
الوصول للمادة أونلاين:	http://journal.frontiersin.org/article/10.3389/fimmu.2018.00239/full
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!